Literature DB >> 22710867

Relation between microRNA expression in peritoneal dialysis effluent and peritoneal transport characteristics.

Jin Chen1, Philip Kam-Tao, Bonnie Ching-Ha Kwan, Kai-Ming Chow, Ka-Bik Lai, Cathy Choi-Wan Luk, Cheuk-Chun Szeto.   

Abstract

BACKGROUND: The role of microRNAs (miRNAs) in peritoneal transport is uncertain.
METHODS: We studied 82 new peritoneal dialysis (PD) patients, 22 prevalent patients without ultrafiltration problem, and 6 patients with documented ultrafiltration problem. Peritoneal transport was determined by standard peritoneal equilibration test (PET). RNA was extracted from the PD effluent after PET, and intra-peritoneal expression of miRNA targets were quantified.
RESULTS: There were significant difference in the PDE expressions of miR-15a and miR-21. There were modest inverse correlations between ultrafiltration volume and PDE expression of miR-17 (r= -0.198, p =0.041) and miR-377 (r=-0.201, p=0.041). There was an inverse correlations between dialysate-to-plasma creatinine concentration at 4 hours and PDE expression of miR-192 (r=-0.199, p=0.040); while mass transfer area coefficient of creatinine correlated with PDE expression of miR-192 (r=-0.191, p=0.049) and miR-377 (r=0.201, p=0.041). Amongst 7 randomly selected patients who had repeat PET after one year, there was a significant correlation between baseline PDE expression of miR-377 and change in ultrafiltration volume (r=-0.852, p=0.015).
CONCLUSION: The miRNA expression in PDE, including miR-15a, miR-17, miR-21, miR-30, miR-192, and miR-377, correlated with peritoneal transport characteristics. Our result suggests that miRNA may play a role in the regulation of peritoneal membrane function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710867      PMCID: PMC3810781          DOI: 10.3233/DMA-2012-0901

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  8 in total

1.  Selective secretion of microRNA in CNS system.

Authors:  Qipeng Zhang; Jie Xu; Qun Chen; Xi Chen; Ke Zen; Chen-Yu Zhang
Journal:  Protein Cell       Date:  2013-04-03       Impact factor: 14.870

2.  A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis.

Authors:  Fan Lin; Xu Wu; Huidi Zhang; Xiaohan You; Zhoucang Zhang; Rongrong Shao; Chaoxing Huang
Journal:  BMC Nephrol       Date:  2015-04-09       Impact factor: 2.388

3.  Peritoneal dialysis effluent-derived exosomal miR-432-5p: an assessment tool for peritoneal dialysis efficacy.

Authors:  Yan Tong; Jun-Yan Fang; A-Hui Song; Hai Deng; Pu Li; Ze-Hui Huang; Ou-Yang Ji; Xiao-Lin Ge; Tong-Ying Zhu; Ying-Li Liu
Journal:  Ann Transl Med       Date:  2022-03

Review 4.  microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis.

Authors:  Melisa Lopez-Anton; Timothy Bowen; Robert H Jenkins
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

Review 5.  Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis.

Authors:  Raffaele Strippoli; Roberto Moreno-Vicente; Cecilia Battistelli; Carla Cicchini; Valeria Noce; Laura Amicone; Alessandra Marchetti; Miguel Angel Del Pozo; Marco Tripodi
Journal:  Stem Cells Int       Date:  2016-01-31       Impact factor: 5.443

Review 6.  MicroRNAs Involvement in Renal Pathophysiology: A Bird's Eye View.

Authors:  P Jaswani; S Prakash; A Dhar; R K Sharma; N Prasad; S Agrawal
Journal:  Indian J Nephrol       Date:  2017 Sep-Oct

Review 7.  IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.

Authors:  Vanessa Marchant; Antonio Tejera-Muñoz; Laura Marquez-Expósito; Sandra Rayego-Mateos; Raul R Rodrigues-Diez; Lucia Tejedor; Laura Santos-Sanchez; Jesús Egido; Alberto Ortiz; Jose M Valdivielso; Donald J Fraser; Manuel López-Cabrera; Rafael Selgas; Marta Ruiz-Ortega
Journal:  Biomolecules       Date:  2020-09-24

8.  Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids.

Authors:  Henk P Roest; Jan N M IJzermans; Luc J W van der Laan
Journal:  BMC Biotechnol       Date:  2021-08-06       Impact factor: 2.563

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.